CONTACT / EDITORIAL DESK
Send a source note
A route for corrections, citation questions, and clear suggestions about this immune and thymic research digest.
What belongs in a note
The editorial desk welcomes specific corrections about compound identity, study design, citation placement, evidence labels, and language that could blur the line between preclinical research and human outcomes. The most useful note names the page, quotes the relevant passage, identifies the cited reference, and explains the proposed correction in plain language.
Questions about site scope are also appropriate. The scope is limited to Thymosin Alpha-1, thymulin, and KPV as organized in the current reference set. The oncology discussion is confined to immune-adjunct research involving Thymosin Alpha-1. The desk does not evaluate antineoplastons, individual treatment plans, vendors, products, or purchasing questions.
Editorial mailbox
Correspondence may be addressed to editorial@antineoplastonpeptides.com. This mailbox is presented as the publication’s editorial channel. It is not a clinical service, emergency contact, patient intake, or product-support address. Messages seeking diagnosis, dosing, treatment selection, sourcing, or interpretation of personal laboratory results cannot be answered as editorial questions.
A source note should use publicly traceable scholarship where possible and distinguish a published correction from a disagreement about interpretation. Submitted material may be checked against the site’s composed reference corpus before any revision is considered. Inclusion of a link or citation in a message does not guarantee that it will be added.
What happens next
Editorial review focuses on whether the existing wording matches the cited source and preserves the evidence level. Clear factual corrections take priority over requests to promote a compound or broaden a claim. When evidence is preliminary, the language remains preliminary. When a study is negative or inconclusive, that result remains visible.
The desk does not accept testimonials as substitutes for clinical data. Community observations, when present in the source material, remain explicitly labeled as anecdotal, not clinical evidence. Commercial solicitations and requests for endorsements fall outside the publication’s purpose.